« Previous article
Etest®, Bringing On...

10th August 2010  Content supplied by: bioMérieux (Clinical Diagnostics)

VITEK® 2 - Take Your Microbiology Lab to the Next Level

VITEK® 2 is a completely automated system providing same-day identification and antibiotic susceptibility results. These results help clinicians select the best treatment options for therapeutic success, patient outcome and containing healthcare costs.

iom 3184h9a With more than 45 years experience in microbiology, bioMérieux, has taken VITEK® 2 to an even higher level to ensure your lab can deliver more, faster and with greater flexibility. The new additions to VITEK® 2 Systems provide users with:

Greater Work Freedom

  • Eliminate waiting time with Remote Multi-User Access for up to 10 simultaneous users
  • Access VITEK® 2 applications, such as bioART™ and Advanced Expert System™ (AES), directly from anywhere on your network
  • Free up valuable bench space by connecting multiple VITEK® 2 instruments to one PC

iom clin 3184h9b Deliver More, Faster

  • Impact patient management by reporting ID/AST results as soon as they become available. No need to wait for all results to complete.
  • Offer new AST testing for antifungals* (addition of caspofungin, posaconazole, micafungin) and routine streptococcus* (11 antibiotics and Inducible Clindamycin Resistance screen test) for ß-Strep, non-Group B and Viridans Strep
  • Aid clinicians further by designing reports to meet their needs
  • Take greater advantage of AES and bioART™ software by viewing AES interpretations, deduction rules, forcing rules, and graphics directly from your workbench

* availability of new AST cards pending regulatory registrations and approvals as required by local authorities

To find out more about VITEK® 2 visit: www.biomerieux-diagnostics.com/vitek2

Share on:


Date Published: 10th August 2010

Source article link: View

View full company details

Related news

bioMérieux (Clinical Diagnostics)


Marcy L'Etoile


Tel: +[33] 4 78 87 20 00

Email Supplier

View full company details

Related news from bioMérieux (Clinical Diagnostics)